SEC Comment Letter 0000000000-23-004457 to BIOCEPT INC (BIOCQ) (CIK 0001044378)
BIOCEPT INC (BIOCQ) (CIK 0001044378)
Date: May 1, 2023 · CIK: 0001044378 · Accession: 0000000000-23-004457
AI Filing Summary & Sentiment
File numbers found in text: 333-271355
Letter
United States securities and exchange commission logo May 1, 2023 Samuel Riccitelli Interim President and Chief Executive Officer BIOCEPT INC 9955 Mesa Rim Road San Diego, CA 92121 Re:BIOCEPT INC Registration Statement on Form S-1 Filed April 20, 2023 File No. 333-271355 Dear Samuel Riccitelli: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Ansart at 202-551-4511 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Asa Henin
Show Raw Text
United States securities and exchange commission logo
May 1, 2023
Samuel Riccitelli
Interim President and Chief Executive Officer
BIOCEPT INC
9955 Mesa Rim Road
San Diego, CA 92121
Re:BIOCEPT INC
Registration Statement on Form S-1
Filed April 20, 2023
File No. 333-271355
Dear Samuel Riccitelli:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Ansart at 202-551-4511 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Asa Henin